A side view ( xz projection) reveals microglia (green
Invitrogen, Hampton, USA), according to the manufacturers instructions
10.1016/0014-2999(92)90503-v Eur

the expected effect size is small and the onset is slow - Avoid antidepressants in bipolar depression presenting with subtle increased psychomotor tempo, pressured speech and racing thoughts due to the increased risk of switch and potentially rapid cycling - Consider ETC as a viable option for the treatment of bipolar depression resistant to pharmacological treatment - Never treat with antidepressants without a mood stabiliser - If an antidepressant is added, use mainly SSRIs due to their low switch rate - If an antidepressant is used in maintenance treatment, the occurrence of manic/mixed symptoms should be monitored carefully The above recommendation is consistent with current Danish guidelines for the pharmacological treatment of bipolar disorder [42], which recommend lithium, quetiapine and lamotrigine as first-line agents for bipolar I disorder, current depressive episode, in at least 70% of patients, and for bipolar II disorder, current depressive episode, in at least 60%

The presence of steatosis was evaluated through abdominal ultrasound and transient elastography
Among US adults in NHANES, the rate of low serum B12 was 3% at a cutoff of 200 pg/mL and 26% at a cutoff of 350 pg/mL